当前位置: 首页 > 期刊 > 《中国医药科学》 > 2012年第2期
编号:13184211
培美曲塞联合奈达铂治疗晚期乳腺癌的疗效分析(2)
http://www.100md.com 2012年1月15日 《中国医药科学》 2012年第2期
     [参考文献]

    [1] Kim YH,Chung HC,Kang WK,et al.Pemetrexed and cisplatin in patients with advanced gastric cancer:a Korean cancer study group multicenter phaseⅡ stduy[J].Cancer Chemother Pharmacol,2011,62(2):263-270.

    [2] Adjei AA.Pemetrexed(Alimta):a novel multitargeted antifolate angent[J].Expert Rev Anticancer Ther,2011,13(2):145-156.

    [3] Celio L,Buzzoni R,Longarini R,et al.Pemetrexed in gastric cancer:clinical experience and future perspectives[J].Semin Oncol,2011,29(6):63-68.

    [4] Bajetta E,Celio L,Buzzoni R,et al.PhaseⅡ stduy of pemetrexed disodium(Alimta)administered with oral folic acid in patients with advanced gastric cancer[J].Ann Oncol,2011,14(2):1543-1548.

    [5] Celio L,Sternberg CN,Labianca R,et al.Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase Ⅱ stduy[J]. Ann Oncol,2009,27(2):221-226.

    [6] Teicher BA,Chen V,Shih C,et al.Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts[J].Clin Cancer Res,2010,6(3):1016-1018.

    (收稿日期:2012-01-04), http://www.100md.com(孟兆珂)
上一页1 2